Companies › XBIO

XENETIC BIOSCIENCES INC (XBIO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001534525 · EDGAR filings · Updated 2026-05-29

XENETIC BIOSCIENCES INC (XBIO) has reported institutional ownership of 7.4%, with 6 institutional managers holding positions valued at $453.0K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-05-29 — SCHEDULE 13G filed
• 2026-05-14 — SCHEDULE 13G/A filed
• 2026-05-13 — Current report (8-K) filed
• 2026-05-12 — Quarterly report (10-Q) filed
• 2026-04-24 — 10-K/A filed
• 2026-04-24 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, XENETIC BIOSCIENCES INC has 6 institutional holders and institutional ownership of 7.4%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 0 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

EXOZYMES INC (EXOZ) · GeoVax Labs Inc (GOVX) · CADRENAL THERAPEUTICS INC (CVKD) · PROCESSA PHARMACEUTICALS INC (PCSA) · Pulmatrix Inc (PULM) · ENDRA LIFE SCIENCES INC (NDRA)